These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2109876)

  • 1. Alterations of IgE immunoglobulin concentration in the serum after megavoltage radiotherapy with large-field technique in patients with Hodgkin's disease.
    Krüsmann W; Slanina J; Nolte I
    Strahlenther Onkol; 1990 Apr; 166(4):265-70. PubMed ID: 2109876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in isoagglutinin titers after high-voltage therapy with the large-field technic in Hodgkin's disease patients].
    Krüsmann W; Slanina J; Wannenmacher M; Nolte I
    Strahlenther Onkol; 1988 Feb; 164(2):79-84. PubMed ID: 3125619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in concentrations of IgM, IgA and IgM immune globulins after megavolt therapy with the large-field technic in patients with Hodgkin's disease].
    Krüsmann W; Slanina J; Boser F; Löhr GW
    Strahlenther Onkol; 1988 Jun; 164(6):323-9. PubMed ID: 3133799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum IgE in Hodgkin's disease is of polyclonal origin.
    Landaas TO; Grimmer O; Heier HE; Godal T
    Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):377-80. PubMed ID: 121023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgE levels in Hodgkin's disease.
    Thomas MR; Steinberg P; Votaw ML; Bayne NK
    Ann Allergy; 1976 Dec; 37(6):416-9. PubMed ID: 999061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolism of IgE in patients with immunodeficiency states and neoplastic conditions.
    Iio A; Strober W; Broder S; Polmar SH
    J Clin Invest; 1977 May; 59(5):743-55. PubMed ID: 404320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
    Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease.
    Viviani S; Bonfante V; Santoro A; Zanini M; Devizzi L; Di Russo AD; Soncini F; Villani F; Ragni G; Valagussa P; Bonadonna G
    Cancer J Sci Am; 1999; 5(5):275-82. PubMed ID: 10526668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clincal study on serum immunoglobulin E (IgE) concentrations in patients with malignant lymphoma with special reference to Hodgkin's disease (author's transl)].
    Kimura I; Onoshi T; Tanizaki Y; Ueda N
    Rinsho Ketsueki; 1975 Dec; 16(12):1117-23. PubMed ID: 1240980
    [No Abstract]   [Full Text] [Related]  

  • 10. [Present state of the wide-field megavoltage radiotherapy of Hodgkin's disease. Fundamentals, performance, side effects (author's transl)].
    Wannenmacher M; Slanina J; Kuphal K; Bruggmoser G
    Radiologe; 1978 Oct; 18(10):371-87. PubMed ID: 100827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interleukin 4, total and allergen-specific immunoglobulin E antibodies in the blood of individuals with an atopic constitution].
    Paranos S; Pravica V; Bonaci B; Stojković-Mostarica M
    Srp Arh Celok Lek; 1998; 126(3-4):92-6. PubMed ID: 9863362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
    Wang WH; Li YX; Song YW; Jin J; Liu YP; Wang SL; Zhou LQ; Liu XF; Yu ZH; Han JZ
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):218-21. PubMed ID: 16875611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
    Glanzmann C; Veraguth A; Lütolf UM
    Strahlenther Onkol; 1994 Mar; 170(3):140-6. PubMed ID: 8160093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
    Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
    Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-CSF during large field radiotherapy reduces bone marrow recovery capacity.
    Pape H; Orth K; Heese A; Heyll A; Kobbe G; Schmitt G; Niederbichler AD; Peiper M; Schwarz A; Boelke E
    Eur J Med Res; 2006 Aug; 11(8):322-8. PubMed ID: 17052967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung function and serum concentrations of different cytokines in patients submitted to radiotherapy and intermediate/high dose chemotherapy for Hodgkin's disease.
    Villani F; Viola G; Vismara C; Laffranchi A; Di Russo A; Viviani S; Bonfante V
    Anticancer Res; 2002; 22(4):2403-8. PubMed ID: 12174934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884).
    Aleman BM; Girinsky T; van der Maazen RW; Strijk S; Meijnders P; Bortolus R; Olofsen-van Acht MJ; Lybeert ML; Lievens Y; Eghbali H; Noordijk EM; Tomsic R; Meerwaldt JH; Poortmans PM; Smit WG; Pinna A; Henry-Amar M; Raemaekers JM; ;
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1184-90. PubMed ID: 15936157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
    Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.